Rezolute, Inc. (RZLT)
3.10
-0.04
(-1.27%)
USD |
NASDAQ |
May 07, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Rezolute Research and Development Expense (Annual) : 61.53M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| XOMA Royalty Corp. | 1.712M |
| Ligand Pharmaceuticals, Inc. | 81.18M |
| ADMA Biologics, Inc. | 4.762M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |